Dr Martens /£DOCS

07:00
09:10
11:15
13:25
15:30
1D1W1MYTD1Y5YMAX

About Dr Martens

Dr. Martens, also known as Docs or DMs, is a United Kingdom-based company renowned for its iconic range of footwear, alongside a variety of clothing and accessories. The company, headquartered in Wollaston, Northamptonshire, operates primarily in the footwear manufacturing sector. Established in 1947, Dr. Martens has grown to become a symbol of self-expression and counterculture, distributing its products worldwide under the Dr. Martens brand.

Ticker

£DOCS

Primary listing

LSE

Industry

Textiles, Apparel & Luxury Goods

Employees

2,348

ISIN

GB00BL6NGV24

Dr Martens Metrics

BasicAdvanced
£736M
162.53
£0.00
0.15
£0.02
2.42%

What the Analysts think about Dr Martens

Analyst ratings (Buy, Hold, Sell) for Dr Martens stock.

Bulls say / Bears say

Dr. Martens plans to reduce discounting in key markets, including the U.S., aiming for a return to profit growth in the current financial year. (reuters.com)
The company achieved a significant reduction in inventory by £67 million, surpassing their initial target, and decreased net debt by £95 million, strengthening its balance sheet. (tipranks.com)
Dr. Martens' Americas Direct-to-Consumer segment returned to growth in the second half of FY '25, indicating positive market trends. (tipranks.com)
Dr. Martens reported a 41.7% decrease in profit before tax, primarily due to weaker consumer demand in the U.S. market. (retail-insight-network.com)
The company faced operational challenges, including a poorly implemented transition to a Los Angeles distribution center, negatively impacting U.S. sales. (retaildive.com)
Dr. Martens' wholesale revenues declined by 46%, driven by weak performance in the U.S., indicating potential ongoing challenges in that market. (theguardian.com)
Data summarised monthly by Lightyear AI. Last updated on 8 Jul 2025.

Dr Martens Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Dr Martens Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy £DOCS

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

Aug28
Dr Martens
Dividend·Ex-dividend
Oct8
Dr Martens
Dividend·Payment
£0.017Per share
FAQs